Acurx Pharmaceuticals Inc.

09/25/2024 | Press release | Distributed by Public on 09/25/2024 07:15

Presentation at ICDS Conference, September 2024, Microbiome Results from the phase 2, randomized, double-blind study of ibezapolstat compared with vancomycin for the treatment[...]

Acurx Pharmaceuticals Inc. published this content on September 25, 2024, and is solely responsible for the information contained herein. Distributed via Public Technologies (PUBT), unedited and unaltered, on September 25, 2024 at 13:15 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]